Synthon Seeks To Shift Lilly Adcirca Battle To NC
Synthon Pharmaceuticals Inc. is seeking to transfer to its home state of North Carolina a patent battle with Eli Lilly & Co. over the generic-drug maker's attempts to introduce its own...To view the full article, register now.
Already a subscriber? Click here to view full article